A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group (Q45862712)
Jump to navigation
Jump to search
scientific article published in September 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group |
scientific article published in September 1999 |
Statements
1 reference
A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group (English)
1 reference
Shand N
1 reference
Weber F
1 reference
Mariani L
1 reference
Bernstein M
1 reference
Gianella-Borradori A
1 reference
Long Z
1 reference
Sorensen AG
1 reference
Barbier N
1 reference
1 September 1999
1 reference
1 reference
10
1 reference
14
1 reference
2325-2335
1 reference